Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy

Autor:	Kayoko Matsumoto, Nobuyuki Aotsuka, Satoru Takahashi, M Tanaka, Takayoshi Tachibana, Heiwa Kanamori, Ayumi Numata, Masahiro Onoda, Kazuteru Ohashi, Shinichiro Okamoto, H. Sakamaki, Kensuke Usuki, Toru Sakura, Chiaki Nakaseko, Sinichiro Machida, Yoshinobu Kanda, Takeshi Kobayashi, Jun Taguchi, Shingo Yano, J. Kato, Etsuko Yamazaki, Reiko Watanabe, Shin Fujisawa, Jun Ooi, T. Saito
Rok vydání:	2015
Předmět:	Adult Male medicine.medical_specialty Gastroenterology Disease-Free Survival Cell therapy Internal medicine medicine Clinical endpoint Humans Cumulative incidence Clinical significance Prospective Studies Prospective cohort study Aged Transplantation Acute leukemia Receiver operating characteristic business.industry Incidence Incidence (epidemiology) Hematopoietic Stem Cell Transplantation Bacterial Infections Hematology Middle Aged Allografts Surgery Survival Rate Mycoses Hematologic Neoplasms Ferritins Preoperative Period Female business Follow-Up Studies
Zdroj:	Bone Marrow Transplantation. 50:727-733
ISSN:	1476-5365 0268-3369
Popis:	This prospective study aimed to investigate the influence of pretransplant serum ferritin levels on the outcomes of allogeneic hematopoietic SCT (HSCT). In total, 190 patients with acute leukemia or myelodysplastic syndrome were consecutively enrolled. The patients were divided into two groups: low-ferritin group (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5598687c8096dd2e8d893df6f954b5 https://doi.org/10.1038/bmt.2015.17 Zobrazit plný text záznamu Plný text ve formátu PDF